BridgeMD
New treatment option for Lumbar Disc Herniation
Official title A Biomechanical Study of the Lumbar Intervertebral Disc by Lever Positioning Manipulation
ClinicalTrials.gov ID: NCT06872918
What this study is testing
- What it's testing
- Purpose of Study: The purpose of this clinical trial is the clinical efficacy of different trigger modes of lever positioning manipulation (LPM) for the treatment of lumbar disc herniation (LDH). At the same time, the investigators considered from the perspective of virtual simulation and applied 3D finite element technology combined with dynamic capture system and mechanical sensing system to comprehensively evaluate the characteristics of biomechanical effects of different triggering modes of LPM on LDH.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 60. Healthy volunteers may be eligible.
You may be able to join if
- Healthy volunteers:
- Healthy people with no history of lumbar spine disease, aged 20 to 60.
- No obvious lumbar spine pain or previous diagnosis of lumbar spine-related disease.
- Willing to participate in the study and have signed an informed consent form. Patients:
- Aged 20 to 60 years.
You likely can't join if
- Lumbar vertebrae fracture or dislocation.
- Lumbar spine or lumbar soft tissue tumor, tuberculosis.
- Lumbar spine fusion, paravertebral bone bridges, or severe osteoporosis.
- History of lumbar spine surgery.
- History of serious lumbar trauma.
- Lumbar skin inflammation, skin breaks, or other skin conditions.
See the full eligibility criteria
- Healthy volunteers:
- Healthy people with no history of lumbar spine disease, aged 20 to 60.
- No obvious lumbar spine pain or previous diagnosis of lumbar spine-related disease.
- Willing to participate in the study and have signed an informed consent form. Patients:
- Aged 20 to 60 years.
- Diagnosed with L4-L5 lumbar disc herniation by CT or MRI.
- Stable vital signs, no serious systemic diseases, and no complications.
- Willing to accept manipulation as a test subject.
- Lumbar vertebrae fracture or dislocation.
- Lumbar spine or lumbar soft tissue tumor, tuberculosis.
- Lumbar spine fusion, paravertebral bone bridges, or severe osteoporosis.
- History of lumbar spine surgery.
- History of serious lumbar trauma.
- Lumbar skin inflammation, skin breaks, or other skin conditions.
- Serious primary diseases of the cardiac, hepatic, renal, or hematopoietic systems; psychiatric patients.
- Extreme frailty or pregnancy.
- Participation in other manipulative therapies that may interfere with the study.
- Intolerable adverse reactions.
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 60 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.